enVVeno Medical Corp
NASDAQ:NVNO

Watchlist Manager
enVVeno Medical Corp Logo
enVVeno Medical Corp
NASDAQ:NVNO
Watchlist
Price: 5.01 USD 1.62% Market Closed
Updated: May 26, 2024

Intrinsic Value

enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular di... [ Read More ]

The intrinsic value of one NVNO stock under the Base Case scenario is hidden USD. Compared to the current market price of 5.01 USD, enVVeno Medical Corp is hidden .

Key Points:
NVNO Intrinsic Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Backtest
enVVeno Medical Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NVNO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Ask me anything about
enVVeno Medical Corp

Provide an overview of the primary business activities
of enVVeno Medical Corp.

What unique competitive advantages
does enVVeno Medical Corp hold over its rivals?

What risks and challenges
does enVVeno Medical Corp face in the near future?

Has there been any significant insider trading activity
in enVVeno Medical Corp recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for enVVeno Medical Corp.

Provide P/S
for enVVeno Medical Corp.

Provide P/E
for enVVeno Medical Corp.

Provide P/OCF
for enVVeno Medical Corp.

Provide P/FCFE
for enVVeno Medical Corp.

Provide P/B
for enVVeno Medical Corp.

Provide EV/S
for enVVeno Medical Corp.

Provide EV/GP
for enVVeno Medical Corp.

Provide EV/EBITDA
for enVVeno Medical Corp.

Provide EV/EBIT
for enVVeno Medical Corp.

Provide EV/OCF
for enVVeno Medical Corp.

Provide EV/FCFF
for enVVeno Medical Corp.

Provide EV/IC
for enVVeno Medical Corp.

Show me price targets
for enVVeno Medical Corp made by professional analysts.

What are the Revenue projections
for enVVeno Medical Corp?

How accurate were the past Revenue estimates
for enVVeno Medical Corp?

What are the Net Income projections
for enVVeno Medical Corp?

How accurate were the past Net Income estimates
for enVVeno Medical Corp?

What are the EPS projections
for enVVeno Medical Corp?

How accurate were the past EPS estimates
for enVVeno Medical Corp?

What are the EBIT projections
for enVVeno Medical Corp?

How accurate were the past EBIT estimates
for enVVeno Medical Corp?

Compare the revenue forecasts
for enVVeno Medical Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of enVVeno Medical Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of enVVeno Medical Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of enVVeno Medical Corp compared to its peers.

Compare the P/E ratios
of enVVeno Medical Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing enVVeno Medical Corp with its peers.

Analyze the financial leverage
of enVVeno Medical Corp compared to its main competitors.

Show all profitability ratios
for enVVeno Medical Corp.

Provide ROE
for enVVeno Medical Corp.

Provide ROA
for enVVeno Medical Corp.

Provide ROIC
for enVVeno Medical Corp.

Provide ROCE
for enVVeno Medical Corp.

Provide Gross Margin
for enVVeno Medical Corp.

Provide Operating Margin
for enVVeno Medical Corp.

Provide Net Margin
for enVVeno Medical Corp.

Provide FCF Margin
for enVVeno Medical Corp.

Show all solvency ratios
for enVVeno Medical Corp.

Provide D/E Ratio
for enVVeno Medical Corp.

Provide D/A Ratio
for enVVeno Medical Corp.

Provide Interest Coverage Ratio
for enVVeno Medical Corp.

Provide Altman Z-Score Ratio
for enVVeno Medical Corp.

Provide Quick Ratio
for enVVeno Medical Corp.

Provide Current Ratio
for enVVeno Medical Corp.

Provide Cash Ratio
for enVVeno Medical Corp.

What is the historical Revenue growth
over the last 5 years for enVVeno Medical Corp?

What is the historical Net Income growth
over the last 5 years for enVVeno Medical Corp?

What is the current Free Cash Flow
of enVVeno Medical Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for enVVeno Medical Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
enVVeno Medical Corp

Current Assets 43.2m
Cash & Short-Term Investments 42.9m
Other Current Assets 306k
Non-Current Assets 1.6m
PP&E 1.6m
Other Non-Current Assets 31k
Current Liabilities 1.5m
Accounts Payable 604k
Accrued Liabilities 883k
Non-Current Liabilities 973k
Other Non-Current Liabilities 973k
Efficiency

Earnings Waterfall
enVVeno Medical Corp

Revenue
0 USD
Operating Expenses
-23.9m USD
Operating Income
-23.9m USD
Other Expenses
1.8m USD
Net Income
-22.1m USD

Free Cash Flow Analysis
enVVeno Medical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NVNO Profitability Score
Profitability Due Diligence

enVVeno Medical Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

enVVeno Medical Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

NVNO Solvency Score
Solvency Due Diligence

enVVeno Medical Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

enVVeno Medical Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NVNO Price Targets Summary
enVVeno Medical Corp

Wall Street analysts forecast NVNO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVNO is 20.81 USD with a low forecast of 20.6 USD and a high forecast of 21.42 USD.

Lowest
Price Target
20.6 USD
311% Upside
Average
Price Target
20.81 USD
315% Upside
Highest
Price Target
21.42 USD
328% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

NVNO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

NVNO Price
enVVeno Medical Corp

1M 1M
-3%
6M 6M
+31%
1Y 1Y
+57%
3Y 3Y
-11%
5Y 5Y
-89%
10Y 10Y
-96%
Annual Price Range
5.01
52w Low
2.6
52w High
6.65
Price Metrics
Average Annual Return -38.46%
Standard Deviation of Annual Returns 22.88%
Max Drawdown -95%
Shares Statistics
Market Capitalization 66.8m USD
Shares Outstanding 13 330 000
Percentage of Shares Shorted 6.81%

NVNO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

enVVeno Medical Corp Logo
enVVeno Medical Corp

Country

United States of America

Industry

Health Care

Market Cap

66.8m USD

Dividend Yield

0%

Description

enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 24 full-time employees. The company went IPO on 2018-05-31. The firm is focused on improving the standard of care in the treatment of venous disease. The firm is focused on developing tissue-based solutions that are designed for patients with chronic venous insufficiency (CVI). Its lead product, VenoValve, is a porcine based device being developed to surgically implanted in the deep venous system of the leg to treat severe CVI, including the potential to heal recurring venous leg ulcers. The VenoValve is designed to be implanted into the femoral vein of the patient in an open surgical procedure via a five-to-six-inch incision in the upper thigh. The VenoValve is being evaluated in the surgical anti-reflux venous valve endoprosthesis (SAVVE) United States clinical trial. In addition to the VenoValve, the Company is focused on the development of a second device, enVVe, for the treatment of venous disease.

Contact

CALIFORNIA
Irvine
70 Doppler
+19492612900.0
https://envveno.com/

IPO

2018-05-31

Employees

24

Officers

CEO & Director
Mr. Robert A. Berman
CFO, Treasurer & Secretary
Mr. Craig Thomas Glynn
Senior VP & Chief Technology Officer
Dr. Hamed Alavi Ph.D.
Senior VP & Chief Medical Officer
Dr. Marc H. Glickman M.D.
Co-founder
Mr. Warren Hancock
Chief Medical Officer of Outside of United States
Dr. Benedict Broennimann M.D.
Show More
Chief Commercial Officer
Mr. Andrew Cormack
Show Less

See Also

Discover More
What is the Intrinsic Value of one NVNO stock?

The intrinsic value of one NVNO stock under the Base Case scenario is hidden USD.

Is NVNO stock undervalued or overvalued?

Compared to the current market price of 5.01 USD, enVVeno Medical Corp is hidden .